Home > Drug Search >
  • company_query: Alvine
  •   > 
Drug Filter
Category:
chemistry (8) biology (11)
Status:
Approved (4) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (6) Phase Ⅰ (3)
Clinical Stage:
Active (10) Discontinued (5)
Bio-Type:
Gene therapy (2) Vaccine (1) Recombinant cytokines (4) Whole antibody (1) Fusion protein (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Acute lymphoblastic leukaemia (ALL) (1) Anemia (1) Bladder cancer (1) Breast cancer (1) ischaemic heart disorder (2) Community-acquired bacterial pneumonia (CABP) (1) Facial acne vulgaris (1) Hypertension (1) Melanoma (3) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Prostate cancer (1) Dermal scarring (1) Solid tumours (3) Head and neck cancer (1) Leg ulcer (1) Colorectal cancer (1) Diabetic foot ulcers (1) Sarcoma (1) Neutropenia (2) Mycosis fungoides (1) Glioblastoma (2) Mesothelioma (1) Diffuse large B cell lymphoma (1) Muscle spasticity (1) Celiac disease (1) hematological malignancies (1) Cachexia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top